Approval reinforces Myriad’s leadership in comprehensive HRD testing and establishes MyChoice CDx as the only FDA-approved ...

Myriad Genetics receives US FDA approval for MyChoice CDx test as companion diagnostic for Zejula for patients with ovarian cancer: Salt Lake City Thursday, March 19, 2026, 15:00 ...

Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, today announced that the U.S. Food and Drug ...

Myriad Genetics received approval for a diagnostic test aimed at identifying advanced ovarian cancer patients eligible for treatment with Zejula from the Food and Drug Administration.

Researchers at Memorial Sloan Kettering Cancer Center (MSK) have made an important discovery about how genetic mutations in ...

Practice-changing data in endometrial cancer support checkpoint inhibitor–chemotherapy combinations, extending ...

Ajith Kumar, Global Chief Human Resources Officer (CHRO) and Chief Operating Officer of Technopark-based Testhouse, a global leader in quality engineering solutions, has been named the CHRO of the ...

Researchers at Memorial Sloan Kettering Cancer Center (MSK) have made an important discovery about how genetic mutations in breast cancer patients can interact and drive resistance to certain drugs ...

HIMS expands its digital care platform with new specialties, lab testing and global moves as it scales personalized ...

New research shows that workers who master everyday AI tools like ChatGPT are earning significantly more, getting promoted ...

Amaravati/Nellore: In a major boost to India’s indigenous defence manufacturing and maritime technology capabilities, ...

Over 24.7 lakh candidates participated in Andhra Pradesh's FLNAT 2026, showcasing impressive attendance and strong administrative support.